Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-047750

Evoke Pharma Inc · EVOK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
LVPMC, LLC
10% Owner
Period of report
Aug 20, 2018
Accepted (ET)
Aug 21, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403708

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 20, 2018P465,116$2.35A1,937,983IDirectly owned by LVP III
Common StockF1Aug 20, 2018P23,256$2.35A96,897IDirectly owned by Associates
Common StockF1Aug 20, 2018P11,628$2.35A48,449IDirectly owned by Partners
Common StockF1holding———5,250IDirectly owned by LVPMC

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses